Physician profile
Michael Sosinski
NPI 1790276582
$6,392.93
in general payments reported to CMS, 2019-2025
27 companies · $2,435 in 2025
The $2,435 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $1,543 · 2021: $332 · 2022: $179 · 2023: $273 · 2024: $539 · 2025: $2,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960 · Travel and Lodging: $1,269 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.63 |
| Travel and Lodging | $1,269.09 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,218.86 | 2019-2025 | Hoffmann, Salvation, Augment Injectable |
| Reel Surgical, INC. | $680.53 | 2020 | |
| Arthrex, INC. | $424.20 | 2020 | |
| Smith+Nephew, INC. | $407.91 | 2019-2025 | Grafix Pl, Stravix Pl, Pico 14 |
| Wright Medical Technology, INC. | $350.86 | 2019-2020 | |
| Bioventus LLC | $227.73 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $166.05 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Amgen INC. | $113.61 | 2024-2025 | Krystexxa |
| Merck Sharp & Dohme LLC | $109.81 | 2019 | |
| Cardiovascular Systems INC. | $101.24 | 2021 | |
| Abbvie INC. | $83.88 | 2023-2025 | Dalvance |
| Kci USA, INC. | $76.89 | 2019-2021 | |
| Organogenesis INC. | $68.47 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $63.07 | 2024-2025 | Nuzyra |
| Orthofix Medical, INC. | $42.34 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Embody, INC. | $39.72 | 2022 | |
| Acera Surgical, INC. | $34.42 | 2022-2023 | Restrata Wound Matrix |
| Ebi, LLC | $24.44 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Next Science LLC | $23.86 | 2023 | Xperience, Surgx, Blastx |
| Abbott Laboratories | $20.20 | 2025 | Eterna |
| Zimmer Biomet Holdings, INC. | $18.63 | 2020 | |
| Biotissue Holdings INC. | $18.49 | 2022 | |
| Grt US Holding, INC. | $18.20 | 2021 | |
| Zimvie INC. | $17.04 | 2023 | |
| Medtronic, INC. | $16.09 | 2023 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $16.04 | 2019 | |
| Arteriocyte Medical Systems, INC. | $10.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sosinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.